A5033784446- Pharmaceutical Practices and Patient Outcomes
- Health Sciences Research and Education
- Innovations in Medical Education
- Antimicrobial Resistance in Staphylococcus
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Online and Blended Learning
- Bacterial biofilms and quorum sensing
- Pharmaceutical studies and practices
- Innovative Teaching Methods
- Medication Adherence and Compliance
- Clostridium difficile and Clostridium perfringens research
- Interprofessional Education and Collaboration
- Safe Handling of Antineoplastic Drugs
- Respiratory Support and Mechanisms
- Problem and Project Based Learning
- Asthma and respiratory diseases
- Health Systems, Economic Evaluations, Quality of Life
American College of Clinical Pharmacy
2020-2024
Pacific University Oregon
2019-2023
Pacific University
2020
Washington University in St. Louis
2018
Abstract The American College of Clinical Pharmacy (ACCP) Pharmacotherapy Didactic Curriculum Toolkit has been used by colleges and schools pharmacy as a guide for curricular development revisions since its inaugural publication in 2009. toolkit was last revised updated the 2019 Publications Committee. 2023 ACCP Committee charged with reviewing Update to determine any necessary revisions/updates. committee tier classifications, shifting focus content within Pharm.D. curriculum. Multiple...
Abstract Introduction The American College of Clinical Pharmacy (ACCP) Pharmacotherapy Didactic Curriculum Toolkit was created by the 2008 ACCP Educational Affairs Committee to provide guidance schools and colleges pharmacy for didactic pharmacotherapy curricular development. toolkit revised updated 2016 Committee. Objectives In accordance with Board Regents decision update every 3 years, 2019 Publications charged updating guide adequate disease state inclusion depth coverage in curricula....
In 2018, chronic obstructive pulmonary disease (COPD) was estimated to affect 16.4 million people, or 6.6% of adults in the United States alone. older prevalence is even higher with reported rates as high 14.2% than 65 years age. COPD a preventable caused by repetitive exposure noxious particles, especially inhaled toxins from cigarette smoke. It associated decreased quality life, increased hospitalization, mortality, and significant financial burden patients health care systems. Senior...
Abstract Medication access is critical to achieving optimal patient outcomes. The 2020 Task Force on Access was charged with developing an ACCP white paper improving medication that addresses barriers such as cost, health disparities, and utilization management practices. This outlines major provides pharmacists professional organizations policy practice recommendations help reduce barriers, enhance access, fulfill the goal of
Abstract This commentary provides an overview of the current literature and best practices for online learning assessment within didactic curriculum pharmacy education, building on 2022 ACCP addressing remote experiential learning. Lessons learned from delivery curricula programs to create optimal environment students are reviewed. Although benefits have been found, such as flexibility, convenience, efficient use time, with similar short‐term student performance, potential long‐term...

 Introductory Pharmacy Practice Experiences (IPPEs) provide early experiential education in the Doctor of (Pharm.D.) curriculum United States (US). In response to Oregon's ‘Stay Home, Save Lives’ executive order issued during COVID-19 pandemic, an online health-system IPPE course was developed simulate practice experiences that have historically been conducted person. This case study describes experience from offered for incoming second-year student pharmacists enrolled a three-year...